Dong Liang Selected Research

COVID-19

4/2021	Surveillance of common respiratory infections during the COVID-19 pandemic demonstrates the preventive efficacy of non-pharmaceutical interventions.
1/2021	FaNet: fast assessment network for the novel coronavirus (COVID-19) pneumonia based on 3D CT imaging and clinical symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong Liang Research Topics

Disease

71	Neoplasms (Cancer) 12/2022 - 10/2003
12	Breast Neoplasms (Breast Cancer) 04/2022 - 06/2011
10	Ovarian Neoplasms (Ovarian Cancer) 10/2016 - 10/2007
9	Hypoxia (Hypoxemia) 12/2020 - 04/2013
8	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2012
8	Inflammation (Inflammations) 01/2022 - 04/2008
7	Infections 01/2022 - 08/2008
7	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 09/2011
7	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 07/2014
6	Glioblastoma (Glioblastoma Multiforme) 07/2022 - 07/2012
6	Obesity 01/2022 - 12/2013
6	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2015
5	Squamous Cell Carcinoma of Head and Neck 08/2022 - 01/2020
5	Lupus Nephritis 09/2018 - 11/2004
5	Carcinogenesis 01/2017 - 12/2010
4	Glioma (Gliomas) 08/2022 - 01/2018
4	Trisomy (Trisomies) 01/2022 - 01/2018
4	Adenocarcinoma 01/2021 - 03/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2018
4	Ovarian Epithelial Carcinoma 01/2018 - 05/2014
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2012 - 02/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2003
3	Triple Negative Breast Neoplasms 01/2022 - 10/2014
3	Carcinoma (Carcinomatosis) 10/2021 - 10/2014
3	Fibrosis (Cirrhosis) 03/2020 - 07/2014
3	Asthma (Bronchial Asthma) 08/2014 - 10/2010
3	Myocardial Infarction 07/2014 - 10/2012
3	Urinary Bladder Neoplasms (Bladder Cancer) 11/2008 - 03/2005
2	Osteoarthritis 08/2022 - 08/2021
2	Premature Birth (Birth, Premature) 01/2022 - 01/2021
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2022
2	Body Weight (Weight, Body) 01/2022 - 03/2020
2	Neuroinflammatory Diseases 01/2022 - 01/2021
2	Weight Loss (Weight Reduction) 01/2022 - 03/2012
2	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 12/2021 - 10/2017
2	Proteinuria 10/2021 - 09/2018
2	Starvation 06/2021 - 12/2005
2	COVID-19 04/2021 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 11/2013
2	Type 2 Diabetes Mellitus (MODY) 12/2020 - 01/2015
2	Aneuploidy (Aneuploid) 01/2020 - 01/2018
2	Insulin Resistance 01/2020 - 07/2011
2	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 10/2016

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 05/2022 - 04/2008
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2003
11	Biomarkers (Surrogate Marker)IBA 11/2019 - 10/2005
9	Biological ProductsIBA 08/2022 - 02/2007
7	Phosphotransferases (Kinase)IBA 02/2022 - 09/2011
7	EnzymesIBA 10/2021 - 03/2005
6	MicroRNAs (MicroRNA)IBA 08/2022 - 12/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2014
5	Long Noncoding RNAIBA 01/2022 - 06/2017
4	CarbonIBA 01/2022 - 10/2014
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2020
4	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 07/2011
4	ParvalbuminsIBA 12/2020 - 06/2015
4	Peptides (Polypeptides)IBA 01/2020 - 03/2004
4	Small Interfering RNA (siRNA)IBA 11/2019 - 07/2012
4	Annexin A5IBA 12/2013 - 10/2003
4	Ion Channels (Ion Channel)IBA 05/2013 - 10/2003
4	Interleukin-18 (Interleukin 18)IBA 02/2007 - 11/2004
3	N-(4-isothiocyanatophenethyl)spiperoneIBA 01/2022 - 11/2019
3	cyanogenIBA 03/2020 - 10/2019
3	hydroxide ionIBA 01/2020 - 11/2013
3	LigandsIBA 11/2019 - 04/2009
3	Messenger RNA (mRNA)IBA 01/2018 - 02/2005
3	Carrier Proteins (Binding Protein)IBA 07/2016 - 08/2006
3	Transcription Factors (Transcription Factor)IBA 01/2015 - 05/2012
3	CytokinesIBA 08/2014 - 07/2011
2	HydrogelsIBA 08/2022 - 04/2009
2	parbendazoleIBA 08/2022 - 05/2022
2	Therapeutic UsesIBA 08/2022 - 05/2022
2	polyethylene glycol polyethyleneimine nanogelIBA 04/2022 - 04/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2020
2	AlbuminsIBA 01/2022 - 10/2021
2	GelatinIBA 01/2022 - 01/2018
2	TOR Serine-Threonine KinasesIBA 01/2022 - 02/2016
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021 - 07/2010
2	Competitive Endogenous RNAIBA 08/2021 - 01/2018
2	ElementsIBA 06/2021 - 05/2012
2	SuspensionsIBA 02/2021 - 05/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2017
2	SolutionsIBA 01/2021 - 01/2016
2	LipopolysaccharidesIBA 01/2021 - 01/2017
2	tacrolimus binding protein 4 (FKBP52)IBA 11/2020 - 01/2016
2	ResveratrolIBA 01/2020 - 08/2015
2	purineIBA 01/2020 - 10/2014
2	GoldIBA 01/2020 - 04/2009
2	Methionine (L-Methionine)FDA Link 01/2020 - 01/2020

Therapy/Procedure

35	Therapeutics 12/2022 - 10/2007
10	Drug Therapy (Chemotherapy) 08/2022 - 12/2013
4	Transplantation 08/2021 - 01/2012
3	Radiotherapy 07/2022 - 03/2015
3	Aftercare (After-Treatment) 12/2020 - 03/2015
2	Nanospheres 08/2022 - 05/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 08/2013
2	Gastrectomy 01/2022 - 12/2013
2	Castration 11/2020 - 01/2016